Regenerex Pharma (RGPX) Long-Term Deferred Tax (2018)
Regenerex Pharma (RGPX) reported Long-Term Deferred Tax of -$160000.0 for Q1 2018.
Regenerex Pharma (RGPX) Long-Term Deferred Tax (2018) Analysis & Trends
Regenerex Pharma (RGPX) has 1 years of Long-Term Deferred Tax data on file, last reported at -$160000.0 in Q1 2018.
- Long-Term Deferred Tax for Q1 2018 came in at -$160000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2018 was -$160000.0 (changed N/A YoY), and the FY2018 annual result was -$160000.0, changed N/A from the prior year.
- Long-Term Deferred Tax steadied at -$160000.0 in Q1 2018 per RGPX's latest filing.
- Over five years, Long-Term Deferred Tax peaked at -$160000.0 in Q1 2018 and troughed at -$160000.0 in Q1 2018.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | -160,000.00 |